Abstract
Purpose
Minimally invasive surgery (MIS) for thymic tumors is now accepted widely, in line with improved surgical techniques; however, we occasionally encounter complicated cases of large tumors or of total thymectomy requiring prolonged operative duration or conversion to an open procedure (OP). We reviewed patients registered in a nationwide database to identify the technical feasibility of MIS for thymic epithelial tumors.
Methods
Data on patients treated surgically between 2017 and 2019 were extracted from the National Clinical Database of Japan. Clinical factors and operative outcomes were calculated by tumor diameter using trend analyses. Perioperative outcomes of MIS for non-invasive thymoma were investigated using propensity score-matched analyses.
Results
MIS was performed in 46.2% of the patients. The operative duration and conversion rate increased with the tumor diameter (p < .001). After propensity score-matching, operative duration and postoperative hospital stay were shorter (p < .001), and the transfusion rate was lower (p = .007) in patients who underwent MIS than in those who underwent OP for thymomas ≥ 5 cm. Among patients who underwent total thymectomy, blood loss was less (p < .001) and the postoperative hospital stay was shorter (p < .001) in those who underwent MIS than in those who underwent OP. There were no significant differences in postoperative complications and mortality.
Conclusions
MIS is technically feasible even for large non-invasive thymomas or for total thymectomy, although the operative duration and open conversion rate increase with the tumor diameter.
Similar content being viewed by others
Data availability
The data underlying this article were provided by National Clinical Database in Japan, with permission. Data will be shared on request to the corresponding author, with the permission of the office of National Clinical Database.
References
Friedant AJ, Handorf EA, Su S, Scott WJ. Minimally invasive versus open thymectomy for thymic malignancies: systematic review and meta-analysis. J Thorac Oncol. 2016;11:30–8.
Burt BM, Yao X, Shrager J, Antonicelli A, Padda S, Reiss J, et al. Determinants of complete resection of thymoma by minimally invasive and open thymectomy: analysis of an international registry. J Thorac Oncol. 2017;12:129–36.
Salfity HV, Timsina L, Ceppa DP, Birdas TJ. Minimally invasive surgery in the management of resectable thymoma: a retrospective analysis from the National Cancer Database. J Thorac Dis. 2021;13:6353–62.
Marulli G, Rea F, Melfi F, Schmid TA, Ismail M, Fanucchi O, et al. Robot-aided thoracoscopic thymectomy for early-stage thymoma: a multicenter European study. J Thorac Cardiovasc Surg. 2012;144:1125–30.
Raja SM, Guptill JT, McConnell A, Al-Khalidi HR, Hartwig MG, Klapper JA. Perioperative outcomes of thymectomy in myasthenia gravis: a thoracic surgery database analysis. Ann Thorac Surg. 2022;113:904–10.
Masaoka A, Yamakawa Y, Niwa H, Fukai I, Kondo S, Kobayashi M, et al. Extended thymectomy for myasthenia gravis patients: a 20-year review. Ann Thorac Surg. 1996;62:853–9.
Endo S, Ikeda N, Kondo T, Nakajima J, Kondo H, Yokoi K, et al. Development of an annually updated Japanese national clinical database for chest surgery in 2014. Gen Thorac Cardiovasc Surg. 2016;64:569–76.
Okumura M, Yoshino I, Yano M, Watanabe S, Tsuboi M, et al. Tumour size determines both recurrence-free survival and disease-specific survival after surgical treatment for thymoma. Eur J Cardiothorac Surg. 2019;56:174–81.
Leuven E, Sianesi B. “PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing” Statistical Software Components S432001. Boston College Department of Economics 2003.
Bayoumi A. “STDDIFF: Stata module to compute standardized differences for continuous and categorical variables,” Statistical Software Components S458275. Boston College Department of Economics, revised 09 Mar 2021. 2016.
Agresti A. Categorical data analysis. 3rd ed. Hoboken, NJ: Wiley; 2013.
Yang CJ, Hurd J, Shah SA, Liou D, Wang H, Backhus LM, et al. A national analysis of open versus minimally invasive thymectomy for stage I to III thymoma. J Thorac Cardiovasc Surg. 2020;160:555–67.
Jurado J, Javidfar J, Newmark A, Lavelle M, Bacchetta M, Gorestein L, et al. Minimally invasive thymectomy and open thymectomy: outcome analysis of 263 patients. Ann Thorac Surg. 2012;94:974–81.
Tagawa T, Yamasaki N, Tsuchiya T, Miyazaki T, Morino S, Akamine S, et al. Thoracoscopic versus transsternal resection for early stage thymoma: long-term outcomes. Surg Today. 2014;44:2275–80.
Gu Z, Chen C, Wang Y, Wei Y, Fu J, Zhang P, et al. Members of the Chinese Alliance for research in Thymomas Video-assisted thoracoscopic surgery versus open surgery for Stage I thymic epithelial tumours: a propensity score-matched study. Eur J Cardiothorac Surg. 2018;54:1037–44.
Manoly I, Whistance RN, Sreekumar R, Khawaja S, Horton JM, Khan AZ, et al. Early and mid-term outcomes of trans-sternal and video-assisted thoracoscopic surgery for thymoma. Eur J Cardiothorac Surg. 2014;45:e187–93.
Hess NR, Sarkaria IS, Pennathur A, Levy RM, Christie NA, Luketich JD. Minimally invasive versus open thymectomy: a systematic review of surgical techniques, patient demographics, and perioperative outcomes. Ann Cardiothorac Surg. 2016;5:1–9.
Burt BM, Nguyen D, Groth SS, Palivela N, Ripley RT, Makris KI, et al. Utilization of minimally invasive thymectomy and margin-negative resection for early-stage thymoma. Ann Thorac Surg. 2019;108:405–11.
Pennathur A, Qureshi I, Schuchert MJ, Dhupar R, Ferson PF, Gooding WE, et al. Comparison of surgical techniques for early-stage thymoma: feasibility of minimally invasive thymectomy and comparison with open resection. J Thorac Cardiovasc Surg. 2011;141:694–701.
Odaka M, Tsukamoto Y, Shibasaki T, Katou D, Mori S, Asano H, et al. Thoracoscopic thymectomy is a feasible and less invasive alternative for the surgical treatment of large thymomas. Interact Cardiovasc Thorac Surg. 2017;25:103–8.
Weng W, Li X, Meng S, Liu X, Peng P, Wang Z, et al. Video-assisted thoracoscopic thymectomy is feasible for large thymomas: a propensity-matched comparison. Interact Cardiovasc Thorac Surg. 2020;30:565–72.
Kimura T, Inoue M, Kadota Y, Shiono H, Shintani Y, Nakagiri T, et al. The oncological feasibility and limitations of video-assisted thoracoscopic thymectomy for early-stage thymomas. Eur J Cardiothorac Surg. 2013;44:e214–8.
Nakagiri T, Inoue M, Shintani Y, Funaki S, Kawamura T, Minami M, et al. Improved procedures and comparative results for video-assisted thoracoscopic extended thymectomy for myasthenia gravis. Surg Endosc. 2015;29:2859–65.
Elsayed HH, Gamal M, Raslan S, Abdel HH. Video-assisted thoracoscopic thymectomy for non-thymomatous myasthenia gravis: a right-sided or left-sided approach? Interact Cardiovasc Thorac Surg. 2017;25:651–3.
Jiang L, Chen H, Hou Z, Qiu Y, Depypere L, Li J, et al. Subxiphoid versus unilateral video-assisted thoracoscopic surgery thymectomy for thymomas: a propensity score matching analysis. Ann Thorac Surg. 2022;113:1656–62.
Yoshino I, Hashizume M, Shimada M, Tomikawa M, Tomiyasu M, Suemitsu R, et al. Thoracoscopic thymomectomy with the da Vinci computer-enhanced surgical system. J Thorac Cardiovasc Surg. 2001;122:783–5.
Marcuse F, Hochstenbag M, De Baets MHV, Bootsma G, Maat APWM, Hoeijmakers JGJ, et al. Robotic thymectomy for thymomas: a retrospective follow-up study in the Netherlands. Ann Thorac Surg. 2022;114:1886–94.
Geraci TC, Ferrari-Light D, Pozzi N, Cerfolio RJ. Midterm results for robotic thymectomy for malignant disease. Ann Thorac Surg. 2021;111:1675–81.
Kang CH, Na KJ, Park S, Park IK, Kim YT. Long-term outcomes of robotic thymectomy in patients with thymic epithelial tumors. Ann Thorac Surg. 2021;112:430–5.
Suda T, Tochii D, Tochii S, Takagi Y. Trans-subxiphoid robotic thymectomy. Interact Cardiovasc Thorac Surg. 2015;20:669–71.
Shimomura M, Ishihara S, Okada S, Inoue M. Robotic subxiphoid-optical thymectomy. Interact Cardiovasc Thorac Surg. 2022;35:ivac104.
Acknowledgements
We thank the data managers and physicians in the institutes participating in the NCD registry and the members of the NCD Committee of The Japanese Association of Chest Surgery. We also thank Ms. Chieko Fujimura (The University of Tokyo) for her help with this article.
Funding
This study received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
Hiroyuki Yamamoto is affiliated with the Department of Healthcare Quality Assessment at the University of Tokyo, which is a social collaboration department supported by grants from National Clinical Database, Johnson & Johnson K.K., and Nipro Co.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Inoue, M., Yamamoto, H., Okada, Y. et al. Perioperative outcomes of minimally invasive surgery for large malignant thymic epithelial tumors and for total thymectomy. Surg Today 53, 1089–1099 (2023). https://doi.org/10.1007/s00595-023-02667-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-023-02667-z